AI in Drug Discovery: What Works, What’s Hype & What Comes Next
Artificial intelligence could transform drug discovery and biotech, but not necessarily in the ways the biggest AI predictions suggest. Where can AI actually make drug development faster and more efficient, and where does the hype collide with the realities of biology?
In this episode of the Making Medicine Podcast, host John Stanford sits down with Dr. Thomas Kaiser, co-founder and Chief Scientific Officer of Avicenna Biosciences and operating partner at DCVC Bio, for a deep dive into AI, machine learning, drug discovery and the future of biotechnology.
Dr. Kaiser shares how Avicenna used a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.